California Biotechnology Company Settles Case Involving False Grant Claims
On September 5, 2018, Sonata Biosciences, Inc. (Sonata), Auburn, California, entered into a $37,716.30 settlement agreement with OIG. The settlement agreement resolves allegations that Sonata knowingly presented to the Department of Health and Human Services (HHS) two specified claims under an HHS grant that Sonata knew or should have known were false or fraudulent. Specifically, OIG alleged that Sonata drew down $37,384.74 from a National Institutes of Health Small Business Innovation Research Grant for costs unrelated to the grant. Senior Counsels Michael Torrisi and David Traskey, assisted by Chief Investigator Jennifer Trussell, represented OIG.
- Date:September 5, 2018
- CMP and Affirmative Exclusions